首页> 外文期刊>Urology >Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
【24h】

Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.

机译:腹腔镜肾结石切除术与标准肾结石切除术治疗上尿路移行细胞癌的疗效比较研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine the oncologic safety of laparoscopic nephroureterectomy (LNU), we compared the long-term oncologic outcome of LNU versus open nephroureterectomy (ONU) in patients with upper tract transitional cell carcinoma. METHODS: A total of 367 nephroureterectomy procedures were performed at our institutes for upper tract transitional cell carcinoma without distant metastases. Of 224 patients without concomitant or previous bladder cancer, 58 underwent LNU with open intact specimen retrieval plus open distal ureter and bladder cuff removal and 166 underwent ONU. Their data were reviewed and analyzed retrospectively. The mean follow-up was 13.6 months (range 14 to 34) for the LNU group and 28.0 months (range 14 to 36) for the ONU group. RESULTS: Bladder recurrence was recognized in 19 patients (32.8%) after LNU at a median follow-up of 5.6 months compared with 63 patients (38.0%) after ONU. Local recurrence only developed in 2 patients (1.1%) after ONU. One port site metastasis occurred in a patient who had undergone LNU. Distant metastases developed in 10 patients (17.2 %) after LNU and 33 patients (19.9%) after ONU. The frequency of bladder recurrence, local recurrence, and distant metastases did not differ significantly between the two groups. The actual disease-free 2-year survival rates were similar (75.6% versus 81.7%). In all patients, the risk of metastases and death increased with advanced tumor stage and grade, but not by surgical procedure. CONCLUSIONS: In the surgical management of upper tract transitional cell carcinoma, LNU does not negatively affect long-term oncologic control and can be considered an alternative modality. Tumor stage and grade are, however, important prognostic factors in the incidence of metastases and cancer-specific mortality.
机译:目的:为了确定腹腔镜肾结直肠癌切除术(LNU)的肿瘤学安全性,我们比较了LNU与开放性肾结石切除术(ONU)在上路移行细胞癌患者中的长期肿瘤学结局。方法:在我院共进行了367例肾结直肠癌切除术,无远处转移。在224例无伴随或先前的膀胱癌的患者中,有58例接受了完整开放的标本取回,远端输尿管和膀胱套囊切除的LNU手术,其中166例接受了ONU。他们的数据进行了回顾和分析。 LNU组的平均随访时间为13.6个月(范围14至34),ONU组的平均随访时间为28.0个月(范围14至36)。结果:LNU术后19例(32.8%)膀胱癌复发被确认,中位随访时间为5.6个月,ONU术后63例(38.0%)。 ONU后仅2例(1.1%)发生局部复发。一名LNU患者发生了一个端口位转移。 LNU术后10例(17.2%)和ONU术后33例(19.9%)发生远处转移。两组之间膀胱复发,局部复发和远处转移的频率无明显差异。实际的无病2年生存率相似(75.6%对81.7%)。在所有患者中,转移和死亡的风险均随着晚期肿瘤分期和等级的增加而增加,但并非通过手术程序而增加。结论:在上道移行细胞癌的外科治疗中,LNU不会对长期的肿瘤控制产生负面影响,可以认为是另一种治疗方式。然而,肿瘤的阶段和等级是转移发生率和癌症特异性死亡率的重要预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号